DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Casak SJ, Donoghue M, Fashoyin-Aje L. et al.
FDA approval summary: atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma.
Clin Cancer Res 2021;
27 (07) 1836-1841
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.